Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fanslow

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Gene|February 12, 1996
Complete nucleotide sequence of the mouse CTLA8 geneZ Yao, M Timour, S Painter, et al.
Transplantation Proceedings|February 1, 1989
Expression of immune cell surface markers in vivo and immune competence in mice by dietary nucleotidesA Kulkarni, W Fanslow, H Higley, et al.
Clinical and Diagnostic Laboratory Immunology|November 1, 1996
Molecular pathology of the X-linked hyper-immunoglobulin M syndrome: detection of wild-type transcripts in a patient with a complex splicing defect of the CD40 ligandR Ameratunga, J McKee, J French, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1995
Epstein-Barr virus-induced human B-cell lymphoma arising in HuPBL-SCID chimeric mice: characterization and the role of CD40 stimulation in their treatment and preventionS Funakoshi, M Beckwith, W Fanslow, et al.
Cancer Research|October 19, 2001
Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatinS Ghamande, B L Hylander, E Oflazoglu, et al.
Chemical Immunology|January 1, 1992
The interleukin-4 receptor: structure, function, and signal transductionM P Beckmann, D Cosman, W Fanslow, et al.
Therapeutic Immunology|April 1, 1994
Interleukin-I antagonistsS K Dower, W Fanslow, C Jacobs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivoL Borges, R E Miller, J Jones, et al.
Surgery|November 1, 1988
The influence of hepatocellular function on NK and T cell tumoricidal activityP T Roughneen, S Kulkarni, S C Kumar, et al.
Immunity|March 10, 2001
ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptorD Cosman, J Müllberg, C L Sutherland, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Gene|February 12, 1996
Complete nucleotide sequence of the mouse CTLA8 geneZ Yao, M Timour, S Painter, et al.
Transplantation Proceedings|February 1, 1989
Expression of immune cell surface markers in vivo and immune competence in mice by dietary nucleotidesA Kulkarni, W Fanslow, H Higley, et al.
Clinical and Diagnostic Laboratory Immunology|November 1, 1996
Molecular pathology of the X-linked hyper-immunoglobulin M syndrome: detection of wild-type transcripts in a patient with a complex splicing defect of the CD40 ligandR Ameratunga, J McKee, J French, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1995
Epstein-Barr virus-induced human B-cell lymphoma arising in HuPBL-SCID chimeric mice: characterization and the role of CD40 stimulation in their treatment and preventionS Funakoshi, M Beckwith, W Fanslow, et al.
Cancer Research|October 19, 2001
Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatinS Ghamande, B L Hylander, E Oflazoglu, et al.
Chemical Immunology|January 1, 1992
The interleukin-4 receptor: structure, function, and signal transductionM P Beckmann, D Cosman, W Fanslow, et al.
Therapeutic Immunology|April 1, 1994
Interleukin-I antagonistsS K Dower, W Fanslow, C Jacobs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivoL Borges, R E Miller, J Jones, et al.
Surgery|November 1, 1988
The influence of hepatocellular function on NK and T cell tumoricidal activityP T Roughneen, S Kulkarni, S C Kumar, et al.
Immunity|March 10, 2001
ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptorD Cosman, J Müllberg, C L Sutherland, et al.
Pageof 2